Notably, bexarotene nearly blocked the growth of ACTH‐secreting tumours (Figure 6A,B), and the tumour weight in the bexarotene group was significantly less than that in the vehicle‐treated group (Figure 6C,D). This evidence concerns the gene POMC and neoplasm.